Pegcetacoplan | Market Exclusivity | US | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Pegcetacoplan
US Exclusivities

ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

Contact Supplier

LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

Contact Supplier

Lee Pharma Ltd: Global supplier of certified APIs and formulations, driven by innovation and regulatory excellence.

Contact Supplier

Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

Contact Supplier

Ethypharm is an international Pharma company with European roots manufacturing and commercializing essential drugs all over the world.

Contact Supplier

Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

Contact Supplier

Pegcetacoplan

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

3 API Suppliers, 1 KDMF, 1 NDC API, 2 Listed Suppliers

3 API Suppliers
1 KDMF
1 NDC API
2 Listed Suppliers

DEVELOPMENTS

76 Drugs in Development

76 Drugs in Development

FINISHED DOSAGE FORMULATIONS

11 FDF Dossiers, 2 FDA Orange Book, 2 Europe, 1 Canada, 6 Australia

11 FDF Dossiers
2 FDA Orange Book
2 Europe
1 Canada
6 Australia

DIGITAL CONTENT

67 News #PharmaBuzz

67 News #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 2 Regulatory FDF Prices, 4 Annual Reports

2 US Medicaid Prescriptions
2 Regulatory FDF Prices
4 Annual Reports

MARKET PLACE

1 APIs

1 APIs

PATENTS & EXCLUSIVITIES

31 US Patents, 5 US Exclusivities, 1 Health Canada Patents

31 US Patents
5 US Exclusivities
1 Health Canada Patents

Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Name Reset all filters

5 All

01 5APELLIS PHARMS

filter Product Reset all filters

5 All

01 5PEGCETACOPLAN

filter Exclusivity Expiration Date Reset all filters

5 All

01 12026-02-08

02 12026-02-22

03 22026-05-14

04 12028-05-14

filter Exclusivity Code Reset all filters

5 All

01 1M-288

02 2NCE

03 1NP

04 1ODE-351

Product Main Page

APELLIS PHARMS

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

PEGCETACOPLAN

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

ODE-351

Exclusivity Expiration Date

2028-05-14

Application Number

215014

Product Number

1

Exclusivity Details

01

APELLIS PHARMS

World Drug Safety EU

Not Confirmed

APELLIS PHARMS

U.S.A

World Drug Safety EU

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

PEGCETACOPLAN

Exclusivity Code : ODE-351

Exclusivity Expiration Date : 2028-05-14

Application Number : 215014

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

APELLIS PHARMS

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

PEGCETACOPLAN

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

NCE

Exclusivity Expiration Date

2026-05-14

Application Number

215014

Product Number

1

Exclusivity Details

02

APELLIS PHARMS

World Drug Safety EU

Not Confirmed

APELLIS PHARMS

U.S.A

World Drug Safety EU

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

PEGCETACOPLAN

Exclusivity Code : NCE

Exclusivity Expiration Date : 2026-05-14

Application Number : 215014

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

APELLIS PHARMS

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

PEGCETACOPLAN

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

M-288

Exclusivity Expiration Date

2026-02-08

Application Number

215014

Product Number

1

Exclusivity Details

03

APELLIS PHARMS

World Drug Safety EU

Not Confirmed

APELLIS PHARMS

U.S.A

World Drug Safety EU

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

PEGCETACOPLAN

Exclusivity Code : M-288

Exclusivity Expiration Date : 2026-02-08

Application Number : 215014

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

APELLIS PHARMS

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

PEGCETACOPLAN

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

NP

Exclusivity Expiration Date

2026-02-22

Application Number

217171

Product Number

1

Exclusivity Details

04

APELLIS PHARMS

World Drug Safety EU

Not Confirmed

APELLIS PHARMS

U.S.A

World Drug Safety EU

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

PEGCETACOPLAN

Exclusivity Code : NP

Exclusivity Expiration Date : 2026-02-22

Application Number : 217171

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

APELLIS PHARMS

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

PEGCETACOPLAN

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

NCE

Exclusivity Expiration Date

2026-05-14

Application Number

217171

Product Number

1

Exclusivity Details

05

APELLIS PHARMS

World Drug Safety EU

Not Confirmed

APELLIS PHARMS

U.S.A

World Drug Safety EU

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

PEGCETACOPLAN

Exclusivity Code : NCE

Exclusivity Expiration Date : 2026-05-14

Application Number : 217171

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!